Ignite Creation Date:
2024-05-06 @ 7:29 PM
Last Modification Date:
2024-10-26 @ 3:07 PM
Study NCT ID:
NCT06029439
Status:
RECRUITING
Last Update Posted:
2024-06-14
First Post:
2023-09-01
Brief Title:
Study to Assess the Safety and Effectiveness of NMRA-335140-501
Sponsor:
Neumora Therapeutics Inc
Organization:
Neumora Therapeutics Inc
Study Overview
Official Title:
Long-term Study to Assess the Safety and Effectiveness of NMRA-335140 in Participants With Major Depressive Disorder
Status:
RECRUITING
Status Verified Date:
2024-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a 52-week open-label extension OLE study that will evaluate the safety tolerability and effectiveness of NMRA-335140 in participants with major depressive disorder MDD Participants who completed a parent study investigating the efficacy of NMRA-335140 as a treatment for MDD ie NMRA-335140-301 NMRA-335140-302 or NMRA-335140-303 who provide informed consent and who have no evidence of safety concerns that would preclude treatment with NMRA-335140 may be enrolled into this extension study
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
True
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| KOASTAL-LT | OTHER | Neumora Therapeutics | None |